BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 10991635)

  • 1. Combined interferon and lamivudine therapy: is this the treatment of choice for patients with chronic hepatitis B virus infection?
    Terrault NA
    Hepatology; 2000 Sep; 32(3):675-7. PubMed ID: 10991635
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronic hepatitis B virus infection].
    Trifan A; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(1):19-27. PubMed ID: 14755965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of lamiduvine-resistant mutant chronic hepatitis B with interferon alpha].
    Pariente A; Tachet A; Poveda JD
    Gastroenterol Clin Biol; 2002 Nov; 26(11):1059-60. PubMed ID: 12483147
    [No Abstract]   [Full Text] [Related]  

  • 4. Lamivudine treatment for children with interferon refractory chronic hepatitis B.
    Koçak N; Saltik IN; Ozen H; Yüce ; Gürakan F
    Hepatology; 2000 Feb; 31(2):545. PubMed ID: 10691379
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of long-term lamivudine in chronic hepatitis B virus-infected children.
    Ozgenç F; Arikan C; Sertoz RY; Nart D; Aydogdu S; Yagci RV
    Antivir Ther; 2004 Oct; 9(5):729-32. PubMed ID: 15535410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-lamivudine combination is no better than lamivudine alone in anti-HBe-positive chronic hepatitis B.
    Akarca US; Ersoz G; Gunsar F; Karasu Z; Saritas E; Yuce G; Batur Y
    Antivir Ther; 2004 Jun; 9(3):325-34. PubMed ID: 15259895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive antiviral effects of lamivudine and alpha-interferon in chronic hepatitis B infection.
    Mutimer D; Dowling D; Cane P; Ratcliffe D; Tang H; O'Donnell K; Shaw J; Elias E; Pillay D
    Antivir Ther; 2000 Dec; 5(4):273-7. PubMed ID: 11142622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined interferon plus lamivudine treatment in young patients with dual HBV (HBeAg positive) and HCV chronic infection.
    Marrone A; Zampino R; D'Onofrio M; Ricciotti R; Ruggiero G; Utili R
    J Hepatol; 2004 Dec; 41(6):1064-5. PubMed ID: 15582146
    [No Abstract]   [Full Text] [Related]  

  • 9. Interferon/long-term lamivudine combination therapy in anti-HBe positive chronic hepatitis B patients.
    Nikolaidis NL; Giouleme OI; Tziomalos KA; Saveriadis AS; Grammatikos N; Doukelis P; Voutsas AD; Vassiliadis T; Patsiaoura K; Orfanou-Koumerkeridou E; Balaska A; Eugenidis NP
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1721-5. PubMed ID: 16246192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic hepatitis B.
    Lok AS
    N Engl J Med; 2002 May; 346(22):1682-3. PubMed ID: 12037146
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of chronic hepatitis B: interferon alfa first.
    Prescrire Int; 2001 Feb; 10(51):17-21. PubMed ID: 11503853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon for treatment of breakthrough infection with hepatitis B virus mutants developing during long-term lamivudine therapy.
    Suzuki F; Tsubota A; Akuta N; Someya T; Kobayashi M; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Miyakawa Y; Kumada H
    J Gastroenterol; 2002; 37(11):922-7. PubMed ID: 12483247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of lamivudine and interferon-alpha combination therapy on chronic hepatitis B].
    Tang Y; Chen G; Zheng R
    Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):89. PubMed ID: 11983118
    [No Abstract]   [Full Text] [Related]  

  • 14. One two tandem of lamivudine and inferferon might work for patients with chronic hepatitis B who failed inferferon monotherapy.
    Kaplan DD; Reddy KR
    Am J Gastroenterol; 2002 Sep; 97(9):2465-7. PubMed ID: 12358276
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of HBV gene variations on disease development and antiviral therapy for patients with chronic hepatitis B.
    Chen JY; Wang LW; Sun XM; Gong ZJ
    Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):393-7. PubMed ID: 16109523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the optimal therapy for chronic hepatitis B?
    Lyra AC; Di Bisceglie AM
    Minerva Med; 2001 Dec; 92(6):431-4. PubMed ID: 11740431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral therapy for treatment-naïve hepatitis B virus patients.
    Lau DT; Membreno FE
    Gastroenterol Clin North Am; 2004 Sep; 33(3):581-99, ix-x. PubMed ID: 15324945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Future perspectives and strategies in managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
    Bourlière M
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S34-6. PubMed ID: 17075495
    [No Abstract]   [Full Text] [Related]  

  • 19. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
    Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
    Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of chronic hepatitis B].
    Dybowska D; Pilarczyk M
    Przegl Epidemiol; 2004; 58 Suppl 1():139-43. PubMed ID: 15807174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.